- Home
- CGEM vs KIND Comparison
CGEM vs KIND Comparison
Compare CGEM & KIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- KIND
- Stock Information
- Founded
- CGEM 2016
- KIND 2011
- Country
- CGEM United States
- KIND United States
- Employees
- CGEM N/A
- KIND N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- KIND Computer Software: Programming Data Processing
- Sector
- CGEM Health Care
- KIND Technology
- Exchange
- CGEM Nasdaq
- KIND Nasdaq
- Market Cap
- CGEM 955.5M
- KIND 993.6M
- IPO Year
- CGEM 2021
- KIND N/A
- Fundamental
- Price
- CGEM $12.54
- KIND $2.57
- Analyst Decision
- CGEM Strong Buy
- KIND Hold
- Analyst Count
- CGEM 7
- KIND 2
- Target Price
- CGEM $31.67
- KIND $2.75
- AVG Volume (30 Days)
- CGEM 537.5K
- KIND 2.2M
- Earning Date
- CGEM 11-07-2024
- KIND 11-06-2024
- Dividend Yield
- CGEM N/A
- KIND N/A
- EPS Growth
- CGEM N/A
- KIND N/A
- EPS
- CGEM N/A
- KIND N/A
- Revenue
- CGEM N/A
- KIND $237,605,000.00
- Revenue This Year
- CGEM N/A
- KIND $13.92
- Revenue Next Year
- CGEM N/A
- KIND $15.11
- P/E Ratio
- CGEM N/A
- KIND N/A
- Revenue Growth
- CGEM N/A
- KIND 9.99
- 52 Week Low
- CGEM $7.64
- KIND $1.32
- 52 Week High
- CGEM $30.19
- KIND $3.00
- Technical
- Relative Strength Index (RSI)
- CGEM 31.78
- KIND 55.20
- Support Level
- CGEM $12.04
- KIND $2.32
- Resistance Level
- CGEM $17.50
- KIND $2.56
- Average True Range (ATR)
- CGEM 1.12
- KIND 0.15
- MACD
- CGEM -0.36
- KIND -0.00
- Stochastic Oscillator
- CGEM 9.15
- KIND 37.04
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services.